BeStock  
Stocks › Biotechnology › BLSM

BlossomHill Therapeutics BLSM

US equityMarket cap rank #3706Biotechnology
$16.61 −$0.68 (-3.93%)
Pre-market · Oct 8, 8:20 am ET · After hours $16.06 -3.31%
Open$17.17
Prev close$17.29
Day range$16.12 – $17.67
Volume253.8K
Market cap$527.95M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership42.2%+42.20 pts vs. prior quarter
Institutions holding11+11 vs. prior quarter
Insider trades (recent)19 buys / 0 sellsNet buying
Short interest0.45% of floatDays to cover 1.0 · as of 15 Sep 2026
Short-sale volume share26.5%5-day average of daily volume

Short-sale volume as % of daily volume

17%23%30%37%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$436.0K (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

+$490.1KSuper−$54.1KBig−$1.3MMid−$226.0KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.3% of shares outstanding.

Largest holders

  • Cormorant Asset Management, LP11.37%
  • OrbiMed Advisors LLC8.54%
  • Perceptive Advisors LLC5.69%
  • The Li and Cui Family Trust5.39%
  • Vivo Capital, LLC5.29%
  • Janus Henderson Group plc3.57%
  • Jingrong Cui3.36%
  • Jingrong Jean Cui3.36%

By investor type

  • VC/PE Fund21.34%
  • Hedge Fund11.37%
  • Individual/Insider7.89%
  • Private Company5.39%
  • Mutual Fund4.09%

Reported short interest has risen from 0.37% to 0.45% of float over the last 3 biweekly reports (14 Aug 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +73,691 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +67,503 0.2%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +24,100 0.1%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,301 0.0%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +2,714,279 8.5%
Cormorant Asset Management, LP Hedge Fund 2026/Q3 +3,614,034 11.4%
The Li and Cui Family Trust Private Company 2026/Q3 +1,714,117 5.4%
Vivo Capital, LLC VC/PE Fund 2026/Q3 +1,681,240 5.3%
Brahma Capital VC/PE Fund 2026/Q3 +578,524 1.8%
Vincent Liptak Individual/Insider 2026/Q3 +134,099 0.4%
Yishan Li Individual/Insider 2026/Q3 -102,971 0.4%
John Schmid Individual/Insider 2026/Q3 +6,000 0.0%
Jason Keyes Individual/Insider 2026/Q3 +700 0.0%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +1,808,533 5.7%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,134,361 3.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Aug 2026 OrbiMed Advisors LLC Open Market Acquisition +625,000 $16.00 2,714,279
9 Aug 2026 OrbiMed Advisors LLC Derivative Exercise and Retained +2,089,279 – 2,714,279
9 Aug 2026 John Schmid Independent Director Open Market Acquisition +6,000 $16.00 6,000
9 Aug 2026 Yishan Li Co-Founder & Executive Chairperson Derivative Exercise and Retained +124,779 – –
9 Aug 2026 Brahma Capital Derivative Exercise and Retained +578,524 – 578,524
9 Aug 2026 Cormorant Asset Management, LP Open Market Acquisition +312,500 $16.00 3,614,034
9 Aug 2026 Cormorant Asset Management, LP Derivative Exercise and Retained +3,301,534 – 3,614,034
9 Aug 2026 Jason Keyes Chief Financial Officer Open Market Acquisition +700 $16.00 700
9 Aug 2026 Vincent Liptak General Counsel & Executive VP Derivative Exercise and Retained +22,687 – 134,099
9 Aug 2026 The Li and Cui Family Trust Derivative Exercise and Retained +1,714,117 – 1,714,117
9 Aug 2026 Vincent Liptak General Counsel & Executive VP Open Market Acquisition +4,700 $16.00 134,099
5 Aug 2026 Carl Gordon Independent Director Other Derivative Acquisition +23,904 $16.00 23,904
5 Aug 2026 John Schmid Independent Director Initial Statement of Beneficial +0 – 67,620
5 Aug 2026 Yishan Li Co-Founder & Executive Chairperson Other Derivative Acquisition +112,701 $16.00 112,701
5 Aug 2026 Yishan Li Co-Founder & Executive Chairperson Initial Statement of Beneficial +0 – 124,779
5 Aug 2026 Sheila Gujrathi Lead Independent Director Initial Statement of Beneficial +0 – 90,160
5 Aug 2026 Cormorant Asset Management, LP Other Derivative Acquisition +23,904 $16.00 23,904
5 Aug 2026 Cormorant Asset Management, LP Initial Statement of Beneficial +0 – 1,701,541
5 Aug 2026 Sundeep Agrawal Independent Director Other Derivative Acquisition +23,904 $16.00 23,904
5 Aug 2026 Sundeep Agrawal Independent Director Initial Statement of Beneficial +0 – 10,671

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 137,567 0.4% 1.0
31 Aug 2026 110,782 0.4% 1.0
14 Aug 2026 111,892 0.4% 1.0

Discussion

No comments yet — be the first to weigh in on BLSM.

Leave a comment

Scroll to Top